Last updated on October 2018

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A


Brief description of study

The primary objective of the study is to evaluate the safety of rFVIIIFc (BIIB031) in previously untreated participants with severe hemophilia A. The secondary objectives are to evaluate the efficacy of rFVIIIFc in the prevention and treatment of bleeding episodes in previously untreated patients (PUPs), to evaluate rFVIIIFc consumption for the prevention and treatment of bleeding episodes in PUPs, and to describe experience with the use of rFVIIIFc for immune tolerance induction (ITI) in participants with inhibitors.

Clinical Study Identifier: NCT02234323

Contact Investigators or Research Sites near you

Start Over

Bioverativ

Research Site
Little Rock, AR United States

Bioverativ

Research Site
Duarte, CA United States

Bioverativ

Research Site
Sacramento, CA United States

Bioverativ

Research Site
San Francisco, CA United States

Bioverativ

Research Site
Torrance, CA United States

Bioverativ

Research Site
Indianapolis, IN United States

Bioverativ

Research Site
Louisville, KY United States

Bioverativ

Research Site
Brewer, ME United States

Bioverativ

Research Site
East Lansing, MI United States

Bioverativ

Research Site
Minneapolis, MN United States

Bioverativ

Research Site
Saint Louis, MO United States

Bioverativ

Research Site
Buffalo, NY United States

Bioverativ

Research Site
New York, NY United States

Bioverativ

Research Site
Rochester, NY United States

Bioverativ

Research Site
Columbus, OH United States

Bioverativ

Research Site
Portland, OR United States

Bioverativ

Research Site
Philadelphia, PA United States

Bioverativ

Research Site
Dallas, TX United States

Bioverativ

Research Site
Milwaukee, WI United States

Bioverativ

Research Site
Brisbane, Australia

Bioverativ

Research Site
Parkville, Australia

Bioverativ

Research Site
Perth, Australia

Bioverativ

Research Site
Westmead, Australia

Bioverativ

Research Site
Campinas, Brazil

Bioverativ

Research Site
Canoas, Brazil

Bioverativ

Research Site
Rio de Janeiro, Brazil

Bioverativ

Research Site
Hamilton, Canada

Bioverativ

Research Site
London, Canada

Bioverativ

Research Site
Toronto, Canada

Bioverativ

Research Site
Caen cedex 9, France

Bioverativ

Research Site
Lille Cedex, France

Bioverativ

Research Site
Nantes Cedex 1, France

Bioverativ

Research Site
Strasbourg, France

Bioverativ

Research Site
Toulouse cedex, France

Bioverativ

Research Site
Tours cedex 9, France

Bioverativ

Research Site
Bonn, Germany

Bioverativ

Research Site
Duesseldorf, Germany

Bioverativ

Research Site
Frankfurt, Germany

Bioverativ

Research Site
Dublin, Ireland

Bioverativ

Research Site
Vicenza, Italy

Bioverativ

Research Site
Bari, Italy

Bioverativ

Research Site
Florence, Italy

Bioverativ

Research Site
Genova, Italy

Bioverativ

Research Site
Milan, Italy

Bioverativ

Research Site
Napoli, Italy

Bioverativ

Research Site
Padova, Italy

Bioverativ

Research Site
Rome, Italy

Bioverativ

Research Site
Leiden, Netherlands

Bioverativ

Research Site
Utrecht, Netherlands

Bioverativ

Research Site
Auckland, New Zealand

Bioverativ

Research Site
Christchurch, New Zealand

Bioverativ

Research Site
Gdansk, Poland

Bioverativ

Research Site
Lublin, Poland

Bioverativ

Research Site
Warszawa, Poland

Bioverativ

Research Site
Barcelona, Spain

Bioverativ

Research Site
Madrid, Spain

Bioverativ

Research Site
Stockholm, Sweden

Bioverativ

Research Site
Cambridge, United Kingdom

Bioverativ

Research Site
Basingstoke, United Kingdom

Bioverativ

Research Site
Whitechapel, United Kingdom

Bioverativ

Research Site
Cardiff, United Kingdom

Bioverativ

Research Site
Sheffield, United Kingdom

Bioverativ

Research Site
Ribeirão Preto, Brazil

Bioverativ

Research Site
São Paulo, Brazil

Bioverativ

Research Site
Le Kremlin Bicêtre cedex, France

Bioverativ

Research Site
Berlin, Germany

Bioverativ

Research Site
Hannöver, Germany

Bioverativ

Research Site
Kraków, Poland

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.